Bone Biologics Corp BBLG shares are trading lower by 38% to $0.48 Friday morning after the company announced it's conducting a public offering and private placement to sell over a million shares of its common stock at $0.64 each, alongside unregistered warrants to purchase more shares.
H.C. Wainwright & Co. is facilitating the offering. The company anticipates gross proceeds of about $729,200, planning to allocate the funds to clinical trials, expanding its patents, and general operational needs.
The offering is set to close around November 20, subject to customary conditions. The warrants, priced at $0.52 per share, will be exercisable upon issuance for a period of five and a half years.
See Also: Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King
According to data from Benzinga Pro, BBLG has a 52-week high of $13.21 and a 52-week low of $0.47.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
